Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure (PRO-CARF)
Covid19

About this trial
This is an interventional treatment trial for Covid19 focused on measuring COVID-19, Severe, Prone positioning, High-flow nasal cannula
Eligibility Criteria
Inclusion Criteria:
- Adult patients with confirmed COVID-19, and requirement of a fraction of inspired oxygen (FiO2) ≥30% through high-flow nasal cannula (HFNC) to maintain a capillary saturation of ≥90%
Exclusion Criteria:
- Less than 18 years-old
- Pregnancy
- Patients with immediate need of invasive mechanical ventilation
- Contraindications for prone positioning therapy
- Do-not-resuscitate or do-not-intubate order
- Refusal of the patient or decision maker to enroll in the study
Sites / Locations
- Hospital Civil Fray Antonio Alcalde
- Hospital General de Occidente
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Standard oxygen therapy
Awake prone positioning
Oxygen therapy through high flow nasal cannula (HFNC). Continuous monitoring of vital signs. Inspired fraction of oxygen will be titrated to maintain a capillary saturation of ≥92%. Prone positioning will be allowed as a rescue therapy.
Oxygen therapy through high flow nasal cannula (HFNC). Patients will be asked to remain in prone position throughout the day as long as possible, with breaks according to tolerance. Pillows will be offered for maximizing comfort at chest, pelvis and knees. Monitoring of vital signs will not be suspended. Inspired fraction of oxygen will be titrated to maintain a capillary saturation of ≥92%.